« Previous
Next »
Titles
- CardioMEMS (tm) HF System (St. Jude Medical, Inc.) and Sacubitril/Valsartan (Entresto (tm), Novartis AG) for management of congestive heart failure: effectiveness, value, and value-based price benchmarks : final report1
- Controversies in migraine management: a technology assessment : final report1
- Controversies in obesity management: a technology assessment : final report1
- Diagnostic tests for Alzheimer's disease: generating and evaluating evidence to inform insurance coverage policy1
- Indication-specific pricing of pharmaceuticals in the United States health care system: a report from the 2015 ICER Membership Policy Summit1
- Insulin degludec (Tresiba??, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report1
- Integrating behavioral health into primary care: a technology assessment : final report1
- Mepolizumab (Nucala??, GlaxoSmithKline plc.) for the treatment of severe asthma with eosinophilia: effectiveness, value, and value-based price benchmarks : final report1
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis: comparative clinical effectiveness and value : evidence report1
- Obeticholic acid for the treatment of primary biliary cholangitis: comparative clinical effectiveness, value, and value-based price benchmarks : evidence report1
- PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report1
- Palliative care in the outpatient setting: a comparative effectiveness report : final report1
- The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection: a technology assessment : final report1
- Using comparative effectiveness research to pay equally for equivalent outcomes: an evaluation of a multi-stakeholder effort focused on prostate cancer treatments1